A coalition of major international NGOs is refusing to comply with Israeli orders to hand over detailed staff information, calling it a safety risk and an obstruction of aid, as tensions escalate following the expulsion of Médecins Sans Frontières.
A new analysis reveals a stark geographic divide in credit health, with residents in several Southern states facing higher long-term mortgage costs due to lower average credit scores, while Northern states benefit from more favorable rates.
In a rare break from Wall Street's typically optimistic consensus, a handful of prominent stocks are receiving bearish price targets that signal deep-seated concerns. We examine the challenges facing Deckers, MSC Industrial, and Guardant Health, and why investors might want to look elsewhere.
The third-quarter earnings season revealed a stark divergence in performance among leading healthcare technology providers. While Omnicell impressed with strong results and a soaring stock, peers like Evolent Health and Astrana Health faced significant market headwinds despite revenue beats.
A sharp supply crunch is driving contract prices for mainstream DRAM memory chips up by as much as 95% quarter-on-quarter in early 2025, according to a revised forecast from market analyst TrendForce.
Amid a market environment of stable rates and mixed sentiment, we highlight three companies—spanning biotech, gaming, and tech hardware—whose current share prices appear significantly below their estimated intrinsic value based on cash flow projections.
As AI spending surges, investors face a classic choice: TSMC, the indispensable manufacturer powering the entire industry, or AMD, the aggressive designer aiming to dethrone Nvidia. We analyze the risk-reward calculus.
While robust cash generation signals financial health, it doesn't guarantee stock outperformance. We analyze three cash-rich firms, highlighting one standout and two where strong cash flow masks underlying risks.
While strong cash generation is a hallmark of a healthy business, it's not the whole story. We analyze three companies with solid cash flow, highlighting one that reinvests for growth and two where underlying risks may outweigh the financial metrics.
The vital Rafah border crossing between Gaza and Egypt has partially reopened after a prolonged closure, a key provision of the US-mediated ceasefire. The move allows for limited humanitarian movement under stringent security oversight by Israel and Egypt.
Cogent Biosciences secures a key FDA Breakthrough Therapy Designation for its bezuclastinib-sunitinib combination in advanced GIST, following promising Phase 3 data that showed a halving of disease progression risk.
A wave of commercial flight disruptions is pushing a new class of travelers toward private aviation, not for opulence but for reliability. We examine the shifting calculus of air travel and what a seat actually costs.
Sanmina posted robust Q4 revenue, fueled by communications and AI infrastructure demand, yet shares fell as investors scrutinized softer margins and the integration of ZT Systems. Analysts on the earnings call zeroed in on the path to profitability and market diversification.
Mexican President Claudia Sheinbaum announces plans to send food and essential supplies to Cuba, vowing to pursue diplomatic channels for fuel shipments despite recent U.S. sanctions threats.
With its core search business resilient, cloud division soaring, and new AI deals like the Apple partnership taking shape, Alphabet enters its February 4 earnings report on a strong note, though regulatory and valuation concerns linger.
The vital Rafah border crossing between Gaza and Egypt has resumed operations for restricted humanitarian and civilian traffic, marking a critical, though tentative, development in the ongoing ceasefire agreement.
The Rafah border crossing between Gaza and Egypt reopened Monday for strictly limited passenger traffic, marking a critical, if symbolic, step in implementing the U.S.-brokered ceasefire. The move follows intense diplomatic efforts and comes as the agreement enters a more complex second phase.
Israel is set to partially reopen the Rafah border crossing with Egypt, allowing limited pedestrian movement for Palestinians. The move, a condition of the U.S.-brokered ceasefire, comes amid ongoing tensions and a continued ban on foreign journalists.
The FDA has cleared Intuitive Surgical's latest robotic system for use in certain heart surgeries, marking a strategic expansion into one of healthcare's largest and most complex service lines and potentially reshaping hospital capital planning for robotics.
Nepali authorities have arrested six executives from travel and rescue companies, alleging a sophisticated fraud scheme involving fabricated high-altitude rescues to bilk international insurers out of nearly $20 million.
